Weigao Orthopedic announced that the company has postponed the R&D center construction project and the orthopedic implant product expansion project until December 2027 until December 2027. Among them, the orthopedic implant product production expansion project was re-validated, and it was confirmed that investment was still necessary and feasible, and it was decided to continue implementing it. This extension only adjusts the scheduled usage status of the project. It does not involve changes in the implementing entity, implementation method, or total investment amount. There are no disguised changes in the investment direction of capital raised or harming shareholders' interests. As of June 30, 2026, the investment schedule for the above two projects was 17.84% and 73.13% respectively, and the marketing network construction project has been completed.

Weigao Orthopedic announced that the company has postponed the R&D center construction project and the orthopedic implant product expansion project until December 2027 until December 2027. Among them, the orthopedic implant product production expansion project was re-validated, and it was confirmed that investment was still necessary and feasible, and it was decided to continue implementing it. This extension only adjusts the scheduled usage status of the project. It does not involve changes in the implementing entity, implementation method, or total investment amount. There are no disguised changes in the investment direction of capital raised or harming shareholders' interests. As of June 30, 2026, the investment schedule for the above two projects was 17.84% and 73.13% respectively, and the marketing network construction project has been completed.